These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34376721)

  • 21. Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients.
    Meng Y; Yang H; Wang W; Tang X; Jiang C; Shen Y; Luo W
    Radiat Oncol; 2019 Jan; 14(1):7. PubMed ID: 30642354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.
    Henkenberens C; Janssen S; Lavae-Mokhtari M; Leni K; Meyer A; Christiansen H; Bremer M; Dickgreber N
    Radiat Oncol; 2016 Feb; 11():12. PubMed ID: 26830686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
    Thomas HMT; Hippe DS; Forouzannezhad P; Sasidharan BK; Kinahan PE; Miyaoka RS; Vesselle HJ; Rengan R; Zeng J; Bowen SR
    Discov Oncol; 2022 Sep; 13(1):85. PubMed ID: 36048266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Dang J; Li G; Lu X; Yao L; Zhang S; Yu Z
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1169-78. PubMed ID: 20130912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
    Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
    Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.
    Boonyawan K; Gomez DR; Komaki R; Xu Y; Nantavithya C; Allen PK; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):919-926. PubMed ID: 29976504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients.
    Saha A; Beasley M; Hatton N; Dickinson P; Franks K; Clarke K; Jain P; Teo M; Murray P; Lilley J
    Radiother Oncol; 2021 Mar; 156():153-159. PubMed ID: 33333139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined Ventilation and Perfusion Imaging Correlates With the Dosimetric Parameters of Radiation Pneumonitis in Radiation Therapy Planning for Lung Cancer.
    Kimura T; Doi Y; Nakashima T; Imano N; Kawabata H; Nishibuchi I; Okabe T; Kenjo M; Ozawa S; Murakami Y; Nagata Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):778-87. PubMed ID: 26530746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy.
    Dang J; Li G; Ma L; Diao R; Zang S; Han C; Zhang S; Yao L
    Acta Oncol; 2013 Aug; 52(6):1175-80. PubMed ID: 23198719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Framework for radiation pneumonitis risk stratification based on anatomic and perfused lung dosimetry.
    Dhami G; Zeng J; Vesselle HJ; Kinahan PE; Miyaoka RS; Patel SA; Rengan R; Bowen SR
    Strahlenther Onkol; 2017 May; 193(5):410-418. PubMed ID: 28255667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Radiation Pneumonitis With Machine Learning in Stage III Lung Cancer: A Pilot Study.
    Yakar M; Etiz D; Metintas M; Ak G; Celik O
    Technol Cancer Res Treat; 2021; 20():15330338211016373. PubMed ID: 33969761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.
    Tucker SL; Xu T; Paganetti H; Deist T; Verma V; Choi N; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):403-410. PubMed ID: 30291994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of the risk factors of radiation pneumonitis and the predictive ability of dosiomics in non-small-cell lung cancer.
    Zhuang L; Bai X; Chen Y; Zhang D; Sheng L; Du X
    Future Oncol; 2023 Oct; 19(32):2157-2169. PubMed ID: 37887073
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
    Faught AM; Yamamoto T; Castillo R; Castillo E; Zhang J; Miften M; Vinogradskiy Y
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):202-209. PubMed ID: 28816147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation pneumonitis prediction model with integrating multiple dose-function features on 4DCT ventilation images.
    Katsuta Y; Kadoya N; Kajikawa T; Mouri S; Kimura T; Takeda K; Yamamoto T; Imano N; Tanaka S; Ito K; Kanai T; Nakajima Y; Jingu K
    Phys Med; 2023 Jan; 105():102505. PubMed ID: 36535238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
    Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
    J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinguishing immune checkpoint inhibitor-related pneumonitis from radiation pneumonitis by CT radiomics features in non-small cell lung cancer.
    Peiliang Wang MD; Yikun Li MM; Mengyu Zhao MM; Jinming Yu MD; Feifei Teng MD
    Int Immunopharmacol; 2024 Feb; 128():111489. PubMed ID: 38266450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosiomics and radiomics improve the prediction of post-radiotherapy neutrophil-lymphocyte ratio in locally advanced non-small cell lung cancer.
    Hou R; Xia W; Zhang C; Shao Y; Zhu X; Feng W; Zhang Q; Yu W; Fu X; Zhao J
    Med Phys; 2024 Jan; 51(1):650-661. PubMed ID: 37963229
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features.
    Huang Y; Feng A; Lin Y; Gu H; Chen H; Wang H; Shao Y; Duan Y; Zhuo W; Xu Z
    Radiat Oncol; 2022 Nov; 17(1):188. PubMed ID: 36397060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.